Conavi Medical Corp
(MENAFN- Baystreet) 07:55 AM EST - Conavi Medical Corp: Announced the completion of the first U.S. placement and clinical cases with OCTIVTM, powered by NovasightTM, its FDA-cleared hybrid intravascular imaging system, at NewYork-Presbyterian/Columbia University Irving Medical Center. Interventional cardiologist Dr. Megha Prasad performed the first cases, marking a milestone in Conavi's U.S. commercial rollout. Conavi Medical Corp
shares V are trading unchanged at $0.10.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment